Stroke treatment firm reels in €3m
This article was originally published in Clinica
Executive Summary
Electrical Brain Synchronisation (EBS) Technologies, a German start-up specialising in treatment of neurological deficits in stroke and brain trauma patients, has raised €3m ($4.3m) in its second financing round. Earlybird Venture Capital was the lead investor; BC Brandenburg Capital and High-Tech Gründerfonds also participated in the financing. EBS is developing a therapy that provides noninvasive electrical stimulation to the brain, using head-mounted electrodes. The therapy aims to help the brain "re-learn" its natural synchronisation, particularly for vision and speech functions, and facilitate better and faster rehabilitation. The €3m raised will enable the Kleinmachnow-based firm to take its medical device to market and carry out further clinical for additional indications.